FDA Authorized Booster for People With Weakened Immune Systems
Estimate impact of high-risk COVID population Background As expected, on August 12, the U.S. Food and Drug Administration (FDA) authorized a booster d...
Estimate impact of high-risk COVID population Background As expected, on August 12, the U.S. Food and Drug Administration (FDA) authorized a booster d...
*Co-Authored By: Brian Maas, RPh Clinical Consultant
© 2023 All rights reserved.